Capitolis Liquid Global Markets LLC Sells 93,000 Shares of Regeneron Pharmaceuticals, Inc. $REGN

robot
Abstract generation in progress

Capitolis Liquid Global Markets LLC significantly reduced its stake in Regeneron Pharmaceuticals Inc. by selling 93,000 shares, decreasing its position by 55.4% to own 75,000 shares valued at $42.17 million. Other institutional investors showed mixed activity, with some increasing their holdings. Regeneron Pharmaceuticals reported strong Q4 earnings, surpassing analyst estimates, and announced an increase in its quarterly dividend, while several analysts have issued “Buy” or “Overweight” ratings with increased price targets for the stock.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pin